Cerebral vasospasm remains a major determinant of delayed cerebral ischemia (DCI) and
poor outcomes after aneurysmal subarachnoid hemorrhage (SAH). This study was aimed to …

Aneurysmal subarachnoid hemorrhage (SAH) has increased with the aging of the
population, but the outcome for elderly SAH patients is very poor. Therefore, predicting the …

Aneurysmal subarachnoid hemorrhage (SAH) has increased with the aging of the
population, but the outcome for elderly SAH patients is very poor. Therefore, predicting the …

Platelet-derived growth factor β (PDGFβ) has been proposed to contribute to the
development of cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH), and …

Object. Cerebral vasospasm remains a devastating medical complication of aneurysmal
subarachnoid hemorrhage (SAH). Reactive oxygen species and subsequent lipid …

Purpose: Pigment epithelium-derived factor (PEDF) is a multifunctional protein with
antiangiogenic, anti-inflammatory, neurotrophic and neurogenic properties. The effect of …

Delayed cerebral ischaemia (DCI) after aneurysmal subarachnoid haemorrhage (aSAH) is a
major contributor to morbidity and mortality. It is currently not possible to reliably predict …

Background Elevated levels of B-type natriuretic peptide (BNP) have been associated with
cardiac dysfunction and adverse neurological outcomes after subarachnoid hemorrhage …

Matricellular proteins have been implicated in pathologies after subarachnoid hemorrhage
(SAH). To find a new therapeutic molecular target, the present study aimed to clarify the …

Under physiological conditions, vasoconstrictors and vasodilators are counterbalanced.
After aneurysmal subarachnoid hemorrhage (SAH) disturbance of this equilibrium may …